There’s a new biotech on the scene after MoonLake Immunotherapeutics launched on a mission to develop sonelokimab, a potential inflammatory diseases drug in-licensed from Germany’s Merck KGaA. The ...
Trailing total returns as of 2/10/2026, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) Return 8885.KL FTSE Bursa Malaysia KLCI (^KLSE) ...
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...
bAirway Research Center North, German Center for Lung Research, LungenClinic Grosshansdorf and Christian Albrechts University of Kiel, Kiel, Germany cSection on Pulmonary and Critical Care Medicine, ...
Introduction As new topical and systemic treatments become available for atopic dermatitis (AD), there is a need to understand how treatments are being used in routine clinical practice, their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results